Are you Dr. Ridley?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 27 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2854 Highway 55 Ste 190
Eagan, MN 55121Phone+1 651-644-4277Fax+1 651-644-4018- Is this information wrong?
Summary
- Dr. David Ridley, MD is a rheumatologist in Eagan, Minnesota. He is currently licensed to practice medicine in Minnesota and Illinois. He is affiliated with M Health Fairview St. John's Hospital.
Education & Training
University of MinnesotaFellowship, Rheumatology, 1981 - 1983
Loyola University Medical CenterResidency, Internal Medicine, 1978 - 1981- University of Minnesota Medical SchoolClass of 1978
Certifications & Licensure
MN State Medical License 1981 - 2024
IL State Medical License 1979 - 1982- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Clinical Trials
- Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- 13 citationsThe Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled T...Jeffrey R. Curtis, Stacey S. Cofield, S. Louis Bridges, John Bassler, Atul Deodhar, Theresa L. Ford, Joseph Huffstutter, Allen Jankeel, Alan Kivitz, Shaila Kamal, Step...> ;Annals of Internal Medicine. 2021 Sep 28
- Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors.X. Han, Francis Lobo, Michael S. Broder, Eunice Chang, Sarah N Gibbs, David J Ridley, Irina Yermilov> ;Journal of Health Economics and Outcomes Research. 2021 May 19
- 7 citationsEarly lymphocyte transformation abnormalities in human immunodeficiency virus infection.D. J. Ridley, R. W. Houk, Michael J. Reid, R. N. Boswell> ;Journal of Clinical Immunology. 1989 Mar 1
Press Mentions
Enzyvant Wins FDA Approval for Congenital Athymia Therapy RethymicOctober 8th, 2021- How to Build a Healthy Organizational Culture – Episode 208 | the Unstuck Church PodcastAugust 25th, 2021
- Prescription Drugs, Global Health, and MoreAugust 5th, 2021
- Join now to see all
Hospital Affiliations
M Health Fairview St. John's HospitalSaint Paul, Minnesota
